{"id":7295,"date":"2021-12-16T07:20:57","date_gmt":"2021-12-16T12:20:57","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/carperitid-acetate-anp-1-28-human-cas-89213-87-6-til-behandling-af-kongestiv-hjertesvigt\/"},"modified":"2021-12-16T07:20:57","modified_gmt":"2021-12-16T12:20:57","slug":"carperitid-acetate-anp-1-28-human-cas-89213-87-6-til-behandling-af-kongestiv-hjertesvigt","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/da\/product\/carperitid-acetate-anp-1-28-human-cas-89213-87-6-til-behandling-af-kongestiv-hjertesvigt\/","title":{"rendered":"Carperitid Acetate\/ ANP 1-28, HUMAN CAS 89213-87-6 Til behandling af kongestiv hjertesvigt"},"content":{"rendered":"

Carperitid Acetate\/ ANP 1-28, HUMAN CAS 89213-87-6 Til behandling af kongestiv hjertesvigt<\/strong><\/h2>\n

Produktnavn: Carperitid Acetate\/ ANP 1-28, HUMAN
\nSekvens\uff1a H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg- Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH\uff0c(Disulfidbro: Cys-Cys)
\nSynonymer: ATRIAL NATRIURETISK PEPTID HUMAN;SER- LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-MET: O-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER- PHE-ARG-TYR[SLRRSSCFGGR-MET: O-DRIGAQSGLGCNSFRY]DISULFIDE BRIDGE CYS7-CYS23.;Carperitidacetat, carperitida;atrialt natriuretisk peptid (1-28) (humant) (trifluoracetatsalt);ahANH- Carperiti; Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe- Arg-Tyr-OH;Atrial natriureticpeptide-28 (huMan) (9CI);Atrial Natriuretic Factor (1-28) (huMan) \u03b1hANF, Carperitid
\nCAS: 89213-87-6
\nMF: C127H203N45O39S3< MW: 3080.44
\nEINECS: 686-482-9
\nProduktkategorier: peptid
\nMol Fil: 89213-87-6.mol<\/p>\n

Carperitid er et 28 aminosyre polypeptid med en stabil sekund\u00e6r struktur og er en cir kulationshormon, der virker vasodilator og vanddrivende. I klinisk praksis skyldes vasodilatationen induceret af carperitid som hovedingrediens binding til ANP (atrial natriuretisk polypeptid)-receptorer i vaskul\u00e6r glat muskulatur, hvilket opn\u00e5s ved at \u00f8ge aktiviteten af guanylatcyclase, hvilket tyder p\u00e5 en reduktion i hjerte-pre- og afterload. <\/p>\n

Carperitid er det \u03b1-humane atrielle natriuretiske peptid (\u03b1-hANP) produceret ved rekombinant teknologi. Det blev introduceret i Japan som en behandling for akut kongestiv hjertesvigt (CHF). Hos hunde med CHF reducerede carperitid signifikant det forh\u00f8jede venstre ventrikul\u00e6re endediastoliske tryk og indekset for myokardieiltforbrug (systolisk blodtryk x hjertefrekvens). I et klinisk fors\u00f8g var carperitid effektivt til at forbedre h\u00e6modynamikken og symptomer hos 60 % af patienterne med akut CHF. Carperitid blev rapporteret at v\u00e6re veltolereret uden signifikante bivirkninger klinisk. En gavnlig effekt p\u00e5 h\u00e6modynamikken er blevet rapporteret hos patienter med kronisk hjertesvigt. Carperitid er ogs\u00e5 i kliniske fors\u00f8g til vedligeholdelse af blodtryk under kirurgiske operationer.<\/p>\n

Anvendelse<\/strong>
\nBehandling af dekompenseret kongestiv hjerteinsufficiens.<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktnavn: Carperitid Acetate\/ ANP 1-28, HUMAN
\nCAS: 89213-87-6
\nMF: C127H203N45O39S3
\nMW: 3080.44
\nEINECS: 686-482-9:
\nMol 89213-87-6.mol<\/p>\n","protected":false},"featured_media":2287,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[493],"product_tag":[2451,2473],"class_list":{"0":"post-7295","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptid-for-det-kardiovaskulaere-system","7":"product_tag-carperitide-acetate-anp-1-28-da","8":"product_tag-human-cas-89213-87-6-for-treatment-of-congestive-heart-failure-da","9":"desktop-align-left","10":"tablet-align-left","11":"mobile-align-left","13":"first","14":"instock","15":"shipping-taxable","16":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product\/7295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/comments?post=7295"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media\/2287"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media?parent=7295"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_brand?post=7295"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_cat?post=7295"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_tag?post=7295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}